Clinical Trials Browser

Phase 1 × Lymphoma, Large B-Cell, Diffuse × tislelizumab × Clear all

NCT05659628 2022-12-21

CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL

Phase 1 Recruiting

Lymphoma, Large B-Cell, Diffuse